What is Cognito Therapeutics worth?
$30.0Mlast known valuation
Cognito Therapeutics last raised $10.2M in its Early Stage VC (Jun 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Cognito Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2024 | Early Stage VC | $10.2M | ▮ | ▮ |
| Jun 2022 | Later Stage VC | $108.8M | ▮ | ▮ |
How Cognito Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Cognito Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Cognito Therapeutics worth?
- Cognito Therapeutics's last known valuation is $30.0M.
- How much has Cognito Therapeutics raised?
- Cognito Therapeutics has raised $264.4M in total funding across 2 recorded rounds.
- When did Cognito Therapeutics last raise?
- Cognito Therapeutics last raised in Jun 2024 (Early Stage VC), raising $10.2M.